EPTMF (Epitomee Medical) Equity-to-Asset: 0.78 (As of Dec. 2025) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EPTMF Epitomee Medical Ltd EPTMF
22 GF Score
Price $0.99
! 3 Warning Signs
View Full Analysis

What is Epitomee Medical Equity-to-Asset?

Epitomee Medical EPTMF 22 Equity-to-Asset is 0.78 as of Dec. 2025, which is 3% below its 10-year median of 0.80. GuruFocus rates EPTMF with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Epitomee Medical ranks better than 72.3% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Epitomee Medical's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $25.96 Mil. Epitomee Medical's Total Assets for the quarter that ended in Dec. 2025 was $33.11 Mil. Therefore, Epitomee Medical's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.78.

The historical rank and industry rank for Epitomee Medical's Equity-to-Asset or its related term are showing as below:

EPTMF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.19   Med: 0.8   Max: 0.9
Current: 0.78

During the past 8 years, the highest Equity to Asset Ratio of Epitomee Medical was 0.90. The lowest was 0.19. And the median was 0.80.

EPTMF's Equity-to-Asset is ranked better than
72.3% of 852 companies
in the Medical Devices & Instruments industry
Industry Median: 0.645 vs EPTMF: 0.78

Epitomee Medical  (OTCPK:EPTMF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Epitomee Medical Equity-to-Asset Related Terms


Epitomee Medical Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Epitomee Medical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epitomee Medical Equity-to-Asset Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial 0.81 0.72 0.86 0.84 0.78

Epitomee Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.84 0.84 0.83 0.78

EPTMF vs ABT, SYK, MDT: Equity-to-Asset Comparison

For the Medical Devices subindustry, Epitomee Medical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Epitomee Medical Equity-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Epitomee Medical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Epitomee Medical's Equity-to-Asset falls into.


EPTMF
22GF Score
Epitomee Medical Ltd EPTMF
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epitomee Medical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Epitomee Medical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=25.961/33.106
=0.78

Epitomee Medical's Equity to Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

Equity to Asset (Q: Dec. 2025 )=Total Stockholders Equity/Total Assets
=25.961/33.106
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.78 mean?
Epitomee Medical (EPTMF) has a Equity-to-Asset of 0.78 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Epitomee Medical and its competitors. This is near median its historical median of 0.80. Over the past decade, Epitomee Medical's Equity-to-Asset has ranged from 0.19 to 0.90. According to the industry distribution chart, Epitomee Medical ranks #236 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 27.7%.
Is Epitomee Medical's Equity-to-Asset too high?
Epitomee Medical's current Equity-to-Asset of 0.78 is near median its 10-year median of 0.80. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 0.90. The Medical Devices & Instruments industry median Equity-to-Asset is 0.65. Epitomee Medical's value of 0.78 is 20.9% above this industry median. Based on the distribution chart, Epitomee Medical ranks #236 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Epitomee Medical has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Epitomee Medical's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Epitomee Medical ranks #236 out of 852 companies for Equity-to-Asset. This puts Epitomee Medical in the upper half of its industry. The industry median Equity-to-Asset is 0.65. Epitomee Medical's value of 0.78 is 20.9% above this benchmark. Historically, Epitomee Medical's own Equity-to-Asset has ranged from 0.19 to 0.90 over the past decade. While the company's 10-year median is 0.80 vs. the industry median of 0.65, Epitomee Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.65, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Epitomee Medical's current Equity-to-Asset of 0.78 is 20.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Epitomee Medical and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epitomee Medical's current Equity-to-Asset is 0.78, which is near median its own 10-year median of 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epitomee Medical stock overvalued right now?
Epitomee Medical (EPTMF) has a current Equity-to-Asset of 0.78. The current Equity-to-Asset is 0.78, which is near median its 10-year median of 0.80 and 20.9% above the Medical Devices & Instruments industry median of 0.65. Epitomee Medical's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Epitomee Medical (EPTMF), the current Equity-to-Asset is 0.78 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epitomee Medical Business Description

Other Exchanges EPIT:Israel
Address Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.
22GF Score

Get the complete analysis for EPTMF

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.99
Price